Investor Presentaiton

Comprehensive clinical program behind Luja™ to demonstrate the clinical relevance and difference Pre-clinical studies In-vivo and in-vitro animal models used to optimize technology features and document the effect. Pilot studies 8 studies comparing Luja vs. conventional catheters¹ involving 160+ users, demonstrating number of flow-stops and residual volumes at first flow stop significantly lower with micro-hole zone catheters as compared to conventional catheters Pivotal studies 2 multinational pivotal studies² involving 110+ users demonstrating the impact on the key risk factors of UTIs Multicenter, randomised cross over trials comparing Luja™ vs standard of care • Endpoints: Residual volume, Flow stops, Blood in urine, QoL The first pivotal study³ showed significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter The second pivotal study confirmed the improved performance of Luja seen in the first study 1 Clinicaltrials.gov references: NCT03337048, NCT04633291, NCT04231149, NCT04250987, NCT04445051, NCT04543136, NCT04557787, NCT05224544. 2 Clinicaltrials.gov references: NCT05485935, NCT05485922 3 Study shows significant improvement in bladder emptying with Coloplast Luja™ compared to competitor catheter 4 The data set from the second pivotal study and other relevant clinical data on Luja is available via this link 37 Coloplast

View entire presentation